Sommar Club review

Sommar is worth comparing if you want to see the full plan payment before an online clinical review. Read the supply and billing labels together: a lower four-week equivalent on a longer plan is not a monthly installment. Confirm the pharmacy, state eligibility and selected prescription before paying.

Sommar Club is an online platform for prescription care. Its terms identify Seta Ventures LLC as the operator and Wasef Health, PC or affiliated professional entities as the organizations providing healthcare. Sommar's role and the clinician's role are separate; submitting an application does not guarantee treatment. The contract names these organizations; confirm which clinician and pharmacy would be responsible for your own care.

The current homepage emphasizes sermorelin, while dedicated pages also describe compounded semaglutide, tirzepatide and NAD+ injections. Sermorelin is advertised as a tablet or injection, and a separate page offers a sermorelin-plus-NAD+ bundle. Other peptide names appear in an informational waitlist that expressly says treatment enrollment is not open. Those names should not be read as an available prescription menu.

The terms set a minimum age of 18 to use the service; that is not a guarantee of prescription eligibility. The telehealth consent describes asynchronous questionnaires and messaging. A clinician reviews the information and decides whether prescribing is appropriate; the public treatment pages advertise care-team access and dose adjustments. This is not an emergency service, and the consent says personal data is not monitored continuously. Ask how routine questions, a side effect or an urgent concern would be handled, and whether your proposed treatment requires tests or a live visit.

Policy pages list all 50 states, while the terms condition care on the patient's location and the relevant professional and pharmacy permissions. Washington, DC is not in that enumerated state list. A broad service-area statement does not confirm a particular prescription is available to you. The public pages do not identify the pharmacy that would fill your prescription. One practical detail in the terms deserves attention: medication fulfilled through its pharmacy network is described as arriving without child-resistant packaging.

Semaglutide's four-week supply is advertised at $149, billed monthly. A 12-week supply costs $387 billed every 12 weeks, or $129 per four weeks. A 24-week supply costs $690 billed every 24 weeks, or $115 per four weeks. Tirzepatide's corresponding prices are $249 billed monthly for a four-week supply, $657 every 12 weeks and $1,194 every 24 weeks. Its longer-plan equivalents are $219 and $199 per four weeks. The full longer-plan amount is the bill; the equivalent is a comparison figure. The pages say 12- and 24-week GLP-1 plans ship once.

The listed plans include medication, clinician care, supplies and free shipping, with no membership fee. The site advertises FSA/HSA and Klarna payment; that does not confirm your payment or reimbursement eligibility. NAD+ injection pricing is $169 monthly, $447 every three months or $810 every six months. The latter two amounts correspond to $149 and $135 monthly equivalents.

The homepage advertises sermorelin tablets at $139 billed monthly, only if approved. Injection pricing is $175 month to month, $465 every three months or $834 every six months. A FIRST40 promotion displays a $119 first month; confirm the actual discount and eligibility rather than calculating a discount from the code's name. The bundle page advertises $349 monthly. Tablet quantity, prescription-specific supply and any required testing charges remain to be confirmed.

Cancellation can prevent future billing and shipments through the portal or email; the terms also list phone cancellation. It does not reverse an order already prepared or shipped. The refund policy promises a full refund if the medical provider decides treatment is unsuitable. A request before processing may also qualify, but orders become final once pharmacy preparation begins. For lost, damaged or wrong-temperature shipments, the policy asks for notice within 24 hours and offers replacement if warranted, rather than a shipping-issue refund.

The current GLP-1 pages identify compounded semaglutide and tirzepatide injections. The broader menu includes compounded NAD+ injections and sermorelin tablets or injections. These are descriptions of what the site advertises, not a conclusion that any option is appropriate, effective or available for a particular person. Compounded medicines are not FDA-approved finished products. Ask for the precise preparation, strength, quantity and dispensing pharmacy, and discuss the evidence and risks with the prescribing clinician. Product names and an eligibility form cannot replace that conversation.